The CXCL12/CXCR4/ACKR3 Signaling Axis Regulates PKM2 and Glycolysis

Kathryn E Luker1, Gary D Luker1,2,3

  • 1Department of Radiology, Center for Molecular Imaging, University of Michigan Medical School, 109 Zina Pitcher Place, A524 BSRB, Ann Arbor, MI 48109-2200, USA.

Cells
|June 10, 2022
PubMed

Insights

CXCL12 signaling via CXCR4 and ACKR3 alters protein interactions, reducing pyruvate kinase M2 (PKM2) activity and reprogramming glucose metabolism in cancer. This impacts cell glycolysis and prognosis.

Area of Science:

  • Molecular Biology
  • Cancer Biology
  • Metabolic Pathways

Background:

  • CXCL12 (chemokine ligand) and its receptors CXCR4 and ACKR3 are crucial in cancer progression.
  • β-arrestin 2 links these receptors to signaling pathways and interacts with pyruvate kinase M2 (PKM2), an enzyme involved in cancer metabolism.
  • Dysregulated PKM2 activity and altered cellular metabolism are hallmarks of cancer, contributing to poor prognosis.

Purpose of the Study:

  • To investigate how CXCL12 signaling through CXCR4 and ACKR3 influences protein interactions within the β-arrestin-ERK-PKM2 pathway.
  • To determine the effect of CXCL12 signaling on PKM2 oligomerization and enzymatic activity.
  • To analyze the impact of CXCL12 signaling on glucose metabolism, including glycolysis and the pentose phosphate pathway.

Main Methods:

  • Cell-based assays using luciferase complementation to study protein interactions.
  • Tumor xenograft model of breast cancer in NSG mice.
  • Mass spectrometry to analyze protein interactions and glucose metabolism with isotopically labeled glucose.

Main Results:

  • CXCL12 signaling stimulated protein interactions among β-arrestin 2, PKM2, ERK2, and receptors CXCR4/ACKR3.
  • PKM2 dissociated from β-arrestin 2, and its oligomerization decreased, shifting towards less active dimers/monomers.
  • CXCL12 signaling increased intermediate metabolites in glycolysis and the pentose phosphate pathway, with ACKR3 showing a more significant effect.

Conclusions:

  • CXCL12 signaling reprograms cellular metabolism by regulating PKM2 interactions and oligomerization.
  • The CXCR4/ACKR3-β-arrestin 2-PKM2 axis is a key regulator of metabolic shifts in cancer.
  • Targeting this pathway could offer novel therapeutic strategies for cancer treatment.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.0K
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.7K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
6.2K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.3K